Dr. Weber on Selecting Immunotherapy for Patients With Melanoma

http://youtu.be/b8hJHJDRHtk Jeffery S. Weber, MD, PhD, deputy director of the Laura and Isaac Perlmutter Cancer Center, co-director of the Melanoma Program, and head of Experimental Therapeutics at NYU Langone Medical Center, discusses considering factors when selecting an immunotherapy agent for a patient with melanoma.